IGM Biosciences Alpha and Beta Analysis
| IGMSDelisted Stock | USD 1.27 0.03 2.31% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as IGM Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in IGM Biosciences over a specified time horizon. Remember, high IGM Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to IGM Biosciences' market risk premium analysis include:
Beta (0.19) | Alpha 0.24 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
IGM |
IGM Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. IGM Biosciences market risk premium is the additional return an investor will receive from holding IGM Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IGM Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate IGM Biosciences' performance over market.| α | 0.24 | β | -0.19 |
IGM Biosciences Fundamentals Vs Peers
Comparing IGM Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze IGM Biosciences' direct or indirect competition across all of the common fundamentals between IGM Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as IGM Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of IGM Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing IGM Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare IGM Biosciences to competition |
| Fundamentals | IGM Biosciences | Peer Average |
| Return On Equity | -0.48 | -0.31 |
| Return On Asset | 0.0289 | -0.14 |
| Profit Margin | (0.37) % | (1.27) % |
| Operating Margin | 0.91 % | (5.51) % |
| Current Valuation | (27.73 M) | 16.62 B |
| Shares Outstanding | 36.59 M | 571.82 M |
| Shares Owned By Insiders | 35.39 % | 10.09 % |
IGM Biosciences Opportunities
IGM Biosciences Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | IGM Biosciences Terminates Headquarters Lease Agreement - TipRanks | 05/29/2025 |
2 | IGM Biosciences stock climbs on merger deal | 07/01/2025 |
3 | HAREHOLDER ALERT Class Action Attorney Juan Monteverde Investigates the Merger of IGM ... | 07/02/2025 |
4 | Concentra Group to Acquire IGM Biosciences - MSN | 07/15/2025 |
5 | Will IGM Biosciences Inc. stock benefit from interest rate changes - High-profit stock alerts - jammulinksnews.com | 07/24/2025 |
6 | How does IGM Biosciences Inc. generate profit in a changing economy - Low Risk Growth Plan With Low Risk - jammulinksnews.com | 07/31/2025 |
7 | IGM Biosciences earnings beat by 1.70, revenue topped estimates - Investing.com UK | 08/06/2025 |
About IGM Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including IGM or other delisted stocks. Alpha measures the amount that position in IGM Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
IGM Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of IGM Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, IGM Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of IGM Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of IGM Biosciences. Please utilize our Beneish M Score to check the likelihood of IGM Biosciences' management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with IGM Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in IGM Stock
If you are still planning to invest in IGM Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IGM Biosciences' history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |